ML17355A529: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
(2 intermediate revisions by the same user not shown)
Line 9: Line 9:
| docket = 05000609
| docket = 05000609
| license number =  
| license number =  
| contact person = Montgomery C K, NRR/DLP,  415-3398
| contact person = Montgomery C, NRR/DLP,  415-3398
| case reference number = CAC MF1395
| case reference number = CAC MF1395
| package number = ML17355A553 Pkg.
| package number = ML17355A553 Pkg.
Line 19: Line 19:


=Text=
=Text=
{{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 December 21, 2017
{{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 December 21, 2017 Carolyn Haass Chief Operating Officer Northwest Medical Isotopes, LLC 22500 Hope Dale Avenue Parker, CO 80138
 
Carolyn Haass Chief Operating Officer Northwest Medical Isotopes, LLC 22500 Hope Dale Avenue Parker, CO 80138  


==SUBJECT:==
==SUBJECT:==
NORTHWEST MEDICAL ISOTOPES LLC - REGULATORY INFORMATION CONFERENCE 2018 INVITATION LETTER, SPEAKER CONFIRMATION FORM, AND EXTERNAL AGREEMENT FORM (CAC MF1395)  
NORTHWEST MEDICAL ISOTOPES LLC - REGULATORY INFORMATION CONFERENCE 2018 INVITATION LETTER, SPEAKER CONFIRMATION FORM, AND EXTERNAL AGREEMENT FORM (CAC MF1395)


==Dear Ms. Haass:==
==Dear Ms. Haass:==


It is my pleasure to invite you to participate as a speaker at NRC's 30 th Regulatory Information Conference (RIC). The RIC will be held on March 13-15, 2018, at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.  
It is my pleasure to invite you to participate as a speaker at NRCs 30th Regulatory Information Conference (RIC). The RIC will be held on March 13-15, 2018, at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.
 
This 3-day annual conference is co-sponsored by the Office of Nuclear Reactor Regulation and the Office of Nuclear Regulatory Research, and brings together more than 3,000 participants from over 30 countries representing interested parties from government, industry, international agencies, other interested stakeholders, and members of the public. The RIC fosters communication about NRC activities, and offers a valuable forum to share perspectives on technical issues and other matters facing the nuclear industry.
This 3-day annual conference is co-sponsored by the Office of Nuclear Reactor Regulation and the Office of Nuclear Regulatory Research, and brings together more than 3,000 participants from over 30 countries representing interested parties from government, industry, international agencies, other interested stakeholders, and members of the public. The RIC fosters communication about NRC activities, and offers a valuable forum to share perspectives on technical issues and other matters facing the nuclear industry.  
Your participation as a technical session panelist will bring great value to our session entitled, "Progress Toward a Reliable Domestic Supply of Molybdenum-99," which I will be chairing. The session will be held on Wednesday, March 14, 2018, from 1:30 p.m. to 3:00 p.m. We would like to give participants an opportunity to learn What improvements are underway in construction inspection procedures, operation inspection procedures, guidance, and considerations of the impact of proposed rulemakings, on potential medical isotope facilities? This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensee, the Department of Energy, and other stakeholders. I am anticipating that you can speak about recent Northwest Medical Isotopes activities addressing the future domestic production of Mo-99.
 
Your participation as a technical session panelist will bring great value to our session entitled
, "Progress Toward a Reliable Domestic Supply of Molybdenum-99
," which I will be chairing. The session will be held on Wednesday, March 14, 2018, from 1:30 p.m. to 3:00 p.m. We would like to give participants an opportunity to learn "What improvements are underway in construction inspection procedures, operation inspection procedures, guidance, and considerations of the impact of proposed rulemakings, on potential medical isotope facilities?"  This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensee, the Department of Energy, and other stakeholders. I am anticipating that you can speak about recent Northwest Medical Isotopes activities addressing the future domestic production of Mo-99.  
 
I hope you are able to accept this invitation. You can find RIC-related news and up-to-date conference information by navigating from the NRC's official public website at http://www.nrc.gov/. To confirm your participation, please complete and return the enclosed Speaker Confirmation Form and External Speaker Agreement Form to Cindy Montgomery, our session coordinator, by January 5, 2018
. Please contact Cindy or me if you have questions. Cindy can be reached on 301-415-3398 or cindy.montgomery@nrc.gov.
Sincerely,
 
      /RA/        Alexander Adams, Jr., Chief      Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation U.S. Nuclear Regulatory Commission


Docket No. 50-609  
I hope you are able to accept this invitation. You can find RIC-related news and up-to-date conference information by navigating from the NRCs official public website at http://www.nrc.gov/. To confirm your participation, please complete and return the enclosed Speaker Confirmation Form and External Speaker Agreement Form to Cindy Montgomery, our session coordinator, by January 5, 2018. Please contact Cindy or me if you have questions. Cindy can be reached on 301-415-3398 or cindy.montgomery@nrc.gov.
Sincerely,
                                              /RA/
Alexander Adams, Jr., Chief Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation U.S. Nuclear Regulatory Commission Docket No. 50-609


==Enclosures:==
==Enclosures:==
Line 48: Line 39:
Speaker Confirmation form External Speaker Agreement form
Speaker Confirmation form External Speaker Agreement form


ML17355A529 Letter; ML17355A548 / ML17355A550 Forms ML17355A553 Pkg.     *concurred via email               NRR-088 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME CMontgomery AAdams CMontgomery DATE 12/21/17 12/21/2017 12/21/2017}}
ML17355A529 Letter; ML17355A548 / ML17355A550 Forms ML17355A553 Pkg.               *concurred via email                 NRR-088 OFFICE       NRR/DLP/PRLB/PM       NRR/DLP/PRLB/BC     NRR/DLP/PRLB/PM NAME           CMontgomery               AAdams             CMontgomery DATE             12/21/17               12/21/2017           12/21/2017}}

Latest revision as of 07:54, 22 October 2019

RIC Invitation Letter External Speaker 2018 Haass
ML17355A529
Person / Time
Site: Northwest Medical Isotopes
Issue date: 12/21/2017
From: Alexander Adams
Research and Test Reactors Licensing Projects Branch
To: Haass C
Northwest Medical Isotopes
Montgomery C, NRR/DLP, 415-3398
Shared Package
ML17355A553 Pkg. List:
References
CAC MF1395
Download: ML17355A529 (3)
v • d • e


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 December 21, 2017 Carolyn Haass Chief Operating Officer Northwest Medical Isotopes, LLC 22500 Hope Dale Avenue Parker, CO 80138

SUBJECT:

NORTHWEST MEDICAL ISOTOPES LLC - REGULATORY INFORMATION CONFERENCE 2018 INVITATION LETTER, SPEAKER CONFIRMATION FORM, AND EXTERNAL AGREEMENT FORM (CAC MF1395)

Dear Ms. Haass:

It is my pleasure to invite you to participate as a speaker at NRCs 30th Regulatory Information Conference (RIC). The RIC will be held on March 13-15, 2018, at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.

This 3-day annual conference is co-sponsored by the Office of Nuclear Reactor Regulation and the Office of Nuclear Regulatory Research, and brings together more than 3,000 participants from over 30 countries representing interested parties from government, industry, international agencies, other interested stakeholders, and members of the public. The RIC fosters communication about NRC activities, and offers a valuable forum to share perspectives on technical issues and other matters facing the nuclear industry.

Your participation as a technical session panelist will bring great value to our session entitled, "Progress Toward a Reliable Domestic Supply of Molybdenum-99," which I will be chairing. The session will be held on Wednesday, March 14, 2018, from 1:30 p.m. to 3:00 p.m. We would like to give participants an opportunity to learn What improvements are underway in construction inspection procedures, operation inspection procedures, guidance, and considerations of the impact of proposed rulemakings, on potential medical isotope facilities? This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensee, the Department of Energy, and other stakeholders. I am anticipating that you can speak about recent Northwest Medical Isotopes activities addressing the future domestic production of Mo-99.

I hope you are able to accept this invitation. You can find RIC-related news and up-to-date conference information by navigating from the NRCs official public website at http://www.nrc.gov/. To confirm your participation, please complete and return the enclosed Speaker Confirmation Form and External Speaker Agreement Form to Cindy Montgomery, our session coordinator, by January 5, 2018. Please contact Cindy or me if you have questions. Cindy can be reached on 301-415-3398 or cindy.montgomery@nrc.gov.

Sincerely,

/RA/

Alexander Adams, Jr., Chief Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation U.S. Nuclear Regulatory Commission Docket No. 50-609

Enclosures:

Speaker Confirmation form External Speaker Agreement form

ML17355A529 Letter; ML17355A548 / ML17355A550 Forms ML17355A553 Pkg. *concurred via email NRR-088 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME CMontgomery AAdams CMontgomery DATE 12/21/17 12/21/2017 12/21/2017

Retrieved from "https://kanterella.com/w/index.php?title=ML17355A529&oldid=1961873"